Box score
Nucleus Radiopharma, Inc.
Reported $66.1M sold in a new Form D filed April 11, 2024 (Palo Alto, California).
- Biggest raise
- $66.1M filed Apr 11, 2024
- League
- Bio & Health Other Health Care
- Based in
- Palo Alto, California
- Season rank
- #77 of 1,389 in the Bio & Health League; #303 of 12,443 overall (2024)
- Incorporated
- 2022
- Entity
- Corporation
Form D filings since 2024 2
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-04-11 | New notice | $66.1M | $66.1M | SEC |
| 2024-04-11 | New notice not ranked | $6M | $6M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2004065.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | NGM Bio Holdings, Inc. rookie | Bio & Health | $73.2M |
| 2 | Imperative Care, Inc. | Bio & Health | $72.6M |
| 3 | R3 Vascular Inc. | Bio & Health | $72.5M |
| 4 | Marea Therapeutics, Inc. rookie | Bio & Health | $65.4M |
| 5 | Nalu Medical, Inc. | Bio & Health | $65M |
| 6 | Moximed, Inc | Bio & Health | $62.7M |